In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-15 of 15 for your search:
Drug:  sulindac
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2009-00880, UCI 97-05, R01CA088078, UCIRVINE-UCI-2002-2261, NCT00118365
2.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: CPMC-IRB-1095-072, NCI-P97-0110
3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069390, P30CA006927, FCCC-01031, FCCC-63723, NCI-G02-2080, NCT00039520
4.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor:
Protocol IDs: UUMC-9102, NCI-P92-0018
5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and under at original diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000322260, COG-ARST0321, ARST0321, NCT00068419
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00837, MAY03-1-03, N01CN35000, CDR0000467755, MAYO-030103, MAYO-1395-05, NCT00335504
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Tissue collection/Repository
Status: Completed
Age: 40 to 79
Sponsor: NCI
Protocol IDs: NCI-2009-00836, MAYO-03-1-02, CDR0000496457, MAY03-1-02, N01CN35000, NCT00368927
8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-111, NCT00392665
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000613992, ICORG-06-03, EUDRACT-2006-006051-12, EU-20876, ICORG 06-03 Epi Sulindac, NCT00755976
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: NCI-2009-01115, N01CN35158, UARIZ-08-0841-04, CDR0000633938, 08-0841-04, UARIZ-UAZ05-2-10, NCT00841204
11.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000067922, 1997-96, NCI-P00-0150, UCIRVINE-97-05, NCT00005882
12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: UARIZ-UAZ04-2-02, UARIZ-HSC-0553, UAZ04-2-02, NCT00245024
13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: CDR0000447144, P30CA023074, UARIZ-UAZ04-2-02, UARIZ-HSC-0553, UAZ04-2-02, NCT00245024
14.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and older
Sponsor: NCI
Protocol IDs: NCCTG-909251, MAYO-909251, NCI-P91-0011
15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: MAYO-03-1-BIO, MAYO-CPN0576, MAY03-1-BIO, MAYO-05-004233, NCT00343629
New Search